1. Home
  2. Browse
  3. Practice
  4. Legal & Licensing
  5. Drug Withdrawals/Restricted Sale

Drug Withdrawals/Restricted Sale

121 - 135 of 143 Results
Sort Results:
Commentary: The New Auralgan Formulation May 2008
Patient Education: Neupro Patient Information May 2008
Guideline: Diagnosis and Management of Acute Otitis Media (2004) May 2008
Other: Neupro Healthcare Provider Information May 2008
Article: heparin recall rekindles concern over the safety of drugs made overseas May 2008
Article: People are hearing that the asthma and allergy drug Singulair (montelukast) might increase suicide risk May 2008
Article: Plans to recall the Neupro (rotigotine) patch are bringing up questions about what to do with remaining pharmacy inventory May 2008
Article: The new Auralgan is different from the older Auralgan May 2008
Article: The recent withdrawal of infant cough and cold OTCs has parents asking how to alleviate cold symptoms in young children November 2007
Guideline: Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach (2012) November 2007
Other: Info for Healthcare Providers About the Discontinuation of Exubera November 2007
Commentary: Concerns About OTC Cough and Cold Products in Children November 2007
Patient Education: Infant Cough and Cold Products: Why Are They Gone and What Should I Do? November 2007
Commentary: Exubera Off the Market November 2007
Article: Mucinex and Humibid will soon be the only long-acting guaifenesin products left standing July 2007